Friends Research Hub conducted two recent JCOIN 1.0 studies that offer complementary perspectives on how extended-release buprenorphine (XR-B) can be initiated and sustained across incarceration and reentry. These studies were conducted across several Maryland jails to help correctional systems understand both the feasibility of starting treatment in custody and the patient experience that shapes ongoing treatment.
